1 - 25 of 110 results for author:"Mills K." in Literature citations
Results Customize
› Repeat search in UniProtKB (42)
| Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. Peral de Castro C., Jones S.A., Ni Cheallaigh C., Hearnden C.A., Williams L., Winter J., Lavelle E.C., Mills K.H., Harris J. J. Immunol. 189:4144-4153(2012) · Mapped (29) |
| Osteoarthritis-associated basic calcium phosphate crystals induce pro-inflammatory cytokines and damage-associated molecules via activation of Syk and PI3 kinase. Cunningham C.C., Mills E., Mielke L.A., O'Farrell L.K., Lavelle E., Mori A., McCarthy G.M., Mills K.H., Dunne A. Clin. Immunol. 144:228-236(2012) · Mapped (11) |
| Influences of FTO gene on onset age of adult overweight. Mei H., Chen W., Mills K., He J., Srinivasan S.R., Schork N., Murray S., Berenson G.S. Hum. Genet. 131:1851-1859(2012) · Mapped (4) |
| Activation-induced cytidine deaminase-initiated off-target DNA breaks are detected and resolved during S phase. Hasham M.G., Snow K.J., Donghia N.M., Branca J.A., Lessard M.D., Stavnezer J., Shopland L.S., Mills K.D. J. Immunol. 189:2374-2382(2012) · Mapped (14) |
| Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL. Hannon M.M., Lohan F., Erbilgin Y., Sayitoglu M., O'Hagan K., Mills K., Ozbek U., Keeshan K. Br. J. Haematol. 158:626-634(2012) · Mapped (2) |
| Intermediate Charcot-Marie-Tooth disease due to a novel Trp101Stop myelin protein zero mutation associated with debilitating neuropathic pain. Ramirez J.D., Barnes P.R., Mills K.R., Bennett D.L. Pain 153:1763-1768(2012) · Mapped (2) |
| The identification of a new role for LEKTI in the skin: The use of protein 'bait' arrays to detect defective trafficking of dermcidin in the skin of patients with Netherton syndrome. Bennett K., Heywood W., Di W.L., Harper J., Clayman G.L., Jayakumar A., Callard R., Mills K. J Proteomics 75:3925-3937(2012) · Mapped (2) |
| Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes. Thol F., Yun H., Sonntag A.K., Damm F., Weissinger E.M., Krauter J., Wagner K., Morgan M., Wichmann M., Gohring G. et al. Ann. Hematol. 91:1221-1233(2012) · Mapped (10) |
| Identification of new biomarkers for Down's syndrome in maternal plasma. Heywood W., Mills K., Wang D., Hogg J., Madgett T.E., Avent N.D., Chitty L.S. J Proteomics 75:2621-2628(2012) · Mapped (6) |
| Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Mills K.T., Kobori H., Hamm L.L., Alper A.B., Khan I.E., Rahman M., Navar L.G., Liu Y., Browne G.M., Batuman V. et al. Nephrol. Dial. Transplant. 27:3176-3181(2012) · Mapped (9) |
| Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-gamma+IL-17+ polyfunctional T cells that mediate rejection of murine tumors. Marshall N.A., Galvin K.C., Corcoran A.M., Boon L., Higgs R., Mills K.H. Cancer Res. 72:581-591(2012) · Mapped (2) |
| Interleukin-1 accounts for intrarenal Th17 cell activation during ureteral obstruction. Pindjakova J., Hanley S.A., Duffy M.M., Sutton C.E., Weidhofer G.A., Miller M.N., Nath K.A., Mills K.H., Ceredig R., Griffin M.D. Kidney Int. 81:379-390(2012) · Mapped (2) |
| Structural and mutational studies of a hyperthermophilic intein from DNA polymerase II of Pyrococcus abyssi. Du Z., Liu J., Albracht C.D., Hsu A., Chen W., Marieni M.D., Colelli K.M., Williams J.E., Reitter J.N., Mills K.V. et al. J. Biol. Chem. 286:38638-38648(2011) · Mapped (1) |
| Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. McGillicuddy F.C., Harford K.A., Reynolds C.M., Oliver E., Claessens M., Mills K.H., Roche H.M. Diabetes 60:1688-1698(2011) · Mapped (4) |
| Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production. Brereton C.F., Sutton C.E., Ross P.J., Iwakura Y., Pizza M., Rappuoli R., Lavelle E.C., Mills K.H. J. Immunol. 186:5896-5906(2011) · Mapped (6) |
| Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. Lalor S.J., Dungan L.S., Sutton C.E., Basdeo S.A., Fletcher J.M., Mills K.H. J. Immunol. 186:5738-5748(2011) · Mapped (3) |
| Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. Robb S.A., Sewry C.A., Dowling J.J., Feng L., Cullup T., Lillis S., Abbs S., Lees M.M., Laporte J., Manzur A.Y. et al. Neuromuscul. Disord. 21:379-386(2011) · Mapped (3) |
| IL-27 mediates the response to IFN-beta therapy in multiple sclerosis patients by inhibiting Th17 cells. Sweeney C.M., Lonergan R., Basdeo S.A., Kinsella K., Dungan L.S., Higgins S.C., Kelly P.J., Costelloe L., Tubridy N., Mills K.H. et al. Brain Behav. Immun. 25:1170-1181(2011) · Mapped (1) |
| Omega-3 fatty acids attenuate dendritic cell function via NF-kappaB independent of PPARgamma. Draper E., Reynolds C.M., Canavan M., Mills K.H., Loscher C.E., Roche H.M. J. Nutr. Biochem. 22:784-790(2011) · Mapped (11) |
| ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells. Maas S.A., Donghia N.M., Tompkins K., Foreman O., Mills K.D. BMC Biol. 8:132-132(2010) · Mapped (4) |
| Drosophila Ndfip is a novel regulator of Notch signaling. Dalton H.E., Denton D., Foot N.J., Ho K., Mills K., Brou C., Kumar S. Cell Death Differ. 18:1150-1160(2011) · Mapped (33) |
| Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Masters S.L., Dunne A., Subramanian S.L., Hull R.L., Tannahill G.M., Sharp F.A., Becker C., Franchi L., Yoshihara E., Chen Z. et al. Nat. Immunol. 11:897-904(2010) · Mapped (2) |
| OAS1: a multiple sclerosis susceptibility gene that influences disease severity. O'Brien M., Lonergan R., Costelloe L., O'Rourke K., Fletcher J.M., Kinsella K., Sweeney C., Antonelli G., Mills K.H., O'Farrelly C. et al. Neurology 75:411-418(2010) · Mapped (5) |
| Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Hasham M.G., Donghia N.M., Coffey E., Maynard J., Snow K.J., Ames J., Wilpan R.Y., He Y., King B.L., Mills K.D. Nat. Immunol. 11:820-826(2010) · Mapped (16) |
| Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. Dunne A., Ross P.J., Pospisilova E., Masin J., Meaney A., Sutton C.E., Iwakura Y., Tschopp J., Sebo P., Mills K.H. J. Immunol. 185:1711-1719(2010) · Mapped (4) |